<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01248871</url>
  </required_header>
  <id_info>
    <org_study_id>VAPOR 001</org_study_id>
    <nct_id>NCT01248871</nct_id>
  </id_info>
  <brief_title>&quot;Volatile Anesthetic Protection Of Renal Transplants: VAPOR-1-trail</brief_title>
  <official_title>&quot;Volatile Anesthetic Protection Of Renal Transplants: VAPOR-1-trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the renal protective properties of two currently used anaesthetic techniques - a
      sevoflurane-remifentanil/sufentanil combination with a propofol-remifentanil/sufentanil
      combination for anaesthesia in patients undergoing living donor kidney
      donation/transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the renal protective properties of two currently used anaesthetic techniques</measure>
    <time_frame>participants will be followed for the duration of hospital stay</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Kidney Donation/Transplantation</condition>
  <arm_group>
    <arm_group_label>SEVO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sevoflurane-remifentanil/sufentanil combination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SERE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>volatile agent only during reperfusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>propofol-remifentanil/sufentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>procedure:sevoflurane-remifentanil/sufentanil</intervention_name>
    <description>Active Comparator</description>
    <arm_group_label>SEVO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>volatile agent only during reperfusion</intervention_name>
    <description>Active Comparator</description>
    <arm_group_label>SERE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol-remifentanil/sufentanil</intervention_name>
    <description>Active Comparator</description>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients: Age &gt; 18 years

        Exclusion Criteria:

          -  patient refusal

          -  BMI&lt; 17, &gt;35

          -  neurological disorder

          -  recent use of psycho-active medication, including alcohol.

          -  Donor-recipient couples from the ABO-incompatible program

          -  Altruistic donor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M.M.R.F Struys, Prof.dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>R,J. Ploeg, Prof.dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713 EZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2010</study_first_submitted>
  <study_first_submitted_qc>November 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2010</study_first_posted>
  <last_update_submitted>December 18, 2012</last_update_submitted>
  <last_update_submitted_qc>December 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Groningen</investigator_affiliation>
    <investigator_full_name>MMRF Struys</investigator_full_name>
    <investigator_title>Prof.dr.</investigator_title>
  </responsible_party>
  <keyword>renal</keyword>
  <keyword>transplantation</keyword>
  <keyword>Volatile</keyword>
  <keyword>anesthetic</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

